Page last updated: 2024-08-26

benzylidene glucose and Carcinoma, Anaplastic

benzylidene glucose has been researched along with Carcinoma, Anaplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aastveit, TE; Dornish, JM; Dunsaed, CB; Nesland, JM; Pettersen, EO1
Furuno, T; Kagamimori, S; Kitagawa, M; Komori, Y; Koyama, S; Sato, H; Tatsumura, T; Tsujimoto, M; Yamamoto, K1

Other Studies

2 other study(ies) available for benzylidene glucose and Carcinoma, Anaplastic

ArticleYear
Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013).
    Anti-cancer drugs, 1995, Volume: 6, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma; Female; Glucose; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Ovarian Neoplasms; Pancreatic Neoplasms; Transplantation, Heterologous

1995
4, 6-0-benzylidene-D-glucopyranose (BG) in the treatment of solid malignant tumours, an extended phase I study.
    British journal of cancer, 1990, Volume: 62, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Child; Colonic Neoplasms; Drug Evaluation; Female; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Prostatic Neoplasms; Stomach Neoplasms

1990